Since people that carry the APOE e4 gene variant look to have a higher threat of great complications, the FDA recommends getting tested for that gene variant before beginning treatment with lecanemab or donanemab. All topics completed a set of NAB tests as Section of a more extensive, solitary-session neuropsychological https://mildcognitiveimpairmenttr45443.dailyblogzz.com/34978976/the-best-side-of-neuropsychological-test-battery-for-dementia